Dextran and Related Polysaccharides

Vicki Caligur

BioFiles 2008, 3.10, 17

Dextran

Historically, dextrans had been long recognized as contaminants in sugar processing and other food production. The formation of dextran in wine was shown by Pasteur to be due to the activity of microbes.1 The name dextran was created by Scheibler in 1874, who demonstrated dextran was a carbohydrate with the formula (C6H10O6)n and a positive optical rotation.2

Dextrans are polysaccharides with molecular weights ≥1,000 Dalton, which have a linear backbone of α-linked d-glucopyranosyl repeating units. Three classes of dextrans can be differentiated by their structural features. The pyranose ring structure contains five carbon atoms and one oxygen atom. Class 1 dextrans contain the α(1→6)-linked d-glucopyranosyl backbone modified with small side chains of d-glucose branches with α(1→2), α(1→3), and α(1→4)-linkage (see Figure 1). The class 1 dextrans vary in their molecular weight, spatial arrangement, type and degree of branching, and length of branch chains,3-5 depending on the microbial producing strains and cultivation conditions.6,7 Isomaltose and isomaltotriose are oligosaccharides with the class 1 dextran backbone structure. Class 2 dextrans (alternans) contain a backbone structure of alternating α(1→3) and α(1→6)-linked d-glucopyranosyl units with α(1→3)-linked branches. Class 3 dextrans (mutans) have a backbone structure of consecutive α(1→3)-linked d-glucopyranosyl units with α(1→6)-linked branches. One and two-dimensional NMR spectroscopy techniques have been utilized for the structural analysis of dextrans.8

General structure of class 1 dextrans consisting

Figure 1.General structure of class 1 dextrans consisting of a linear backbone of α(1→6)-linked d-glucopyranosyl repeating units. The dextran may have branches of smaller chains of d-glucose linked to the backbone by α(1→2)- , α(1→3)- or α(1→4)- glycosidic bonds.

The secretion of dextrans provides an opportunity for bacteria to modulate adhesion, e.g. in tooth decay, by having a softer or more rigid bacterial cell surface, depending on the polysaccharide itself and the pH and ionic strength. Low bacterial adhesion occurs at low salt conditions with more rigid polysaccharides and a softer surface, while high bacterial adhesion is obtained with more flexible polysaccharides and a rigid bacterial surface. Polymer elasticity is important for structural integrity. and the pyranose ring is the structural unit controlling the elasticity of the polysaccharide. This elasticity results from a force-induced elongation of the ring structure and a final transition from a chair-like to a boat-like conformation of the glucopyranose ring, which plays an important role in accommodating mechanical stress and modulating ligand binding in biological systems.9 Laboratory experiments have demonstrated that cleavage of the pyranose rings of dextran, amylose, and pullulan convert these different polysaccharide chains into similar structures where all the bonds of the polymer backbone can rotate and align under force. After ring cleavage, single molecules of dextran, amylose, and pullulan display identical elastic behavior as measured by atomic force microscopy.

Dextrans are found as bacterial extracellular polysaccharides. They are synthesized from sucrose by beneficial lactic acid bacteria, such as Leuconostoc mesenteroides and Lactobacillus brevis, but also by the dental plaque-forming species Streptococcus mutans. Bacteria employ dextran in biofilm formation10 or as protective coatings, e.g., to evade host phagocytes in the case of pathogenic bacteria.11

The physical and chemical properties of purified dextrans vary depending on the microbial strains from which they are produced and by the production method, but all are white and tasteless solids. Dextrans have high water solubility and the solutions behave as Newtonian fluids. Solution viscosity depends on concentration, temperature, and molecular weight, which have a characteristic distribution.

The long history of the safety of dextrans has allowed them to be used as additives to food and chemicals, and in pharmaceutical and cosmetics manufacturing.12 Dextrans have been investigated for the targeted and sustained delivery of drugs, proteins, enzymes, and imaging agents.13 In medicine, clinical grades of dextrans with a molecular weight range of 75-100 kDa have been used as blood-plasma volume expanders in transfusions.14 Other applications include the use of dextrans with polyethylene glycol as components of aqueous two-phase systems for the extraction of biochemicals. The hydroxyl groups present in dextran offer many sites for derivatization, and these functionalized glycoconjugates represent a largely unexplored class of biocompatible and environmentally safe compounds.

Cross-linked dextran beads are widely used for chromatography in biochemical research and industry. The classic application of cross-linked dextrans is as gel filtration media in packed-bed columns for the separation and purification of biomolecules with molecular weights in the range of 0.7-200 kDa.15-17 Ion exchange chromatography utilizes dextran that has been derivatized with positively or negatively charged moieties such as carboxymethyl (CM), diethylaminoethyl (DEAE), diethyl(2-hydroxypropyl) aminoethyl (QAE), and sulfopropyl (SP).

We offer a large variety of dextrans with high polydispersity and dextran molecular weight standards with low polydispersity (Mw/Mn values close to 1.0).

Other Polysaccharides

Pullulans are structural polysaccharides primarily produced from starch by the fungus Aureobasidium pullulans.18,19 Pullulans are composed of repeating α(1→6)-linked maltotriose (D-glucopyranosyl-α(1→4)-D-glucopyranosyl-α(1→4)-D-glucose) units with the inclusion of occasional maltotetraose units.20 Diffusion-ordered NMR spectroscopy has been used to achieve a simple estimation of the molecular weight of pullulan.21 The solution properties of pullulan in water have been studied, and it was confirmed that pullulan molecules behave as random coils in aqueous solution.22

Dextrins are composed of D-glucopyranosyl units but have shorter chain lengths than dextrans. They start with a single α(1→6) bond, but continue linearly with α(1→4)-linked D-glucopyranosyl units. Dextrins are usually mixtures derived from the hydrolysis of starch and have found widespread use in the food, paper, textile, and pharmaceutical industries.

Dextran sulfates are derived from dextran via sulfation. They have become indispensable components in many molecular biology techniques, including the transfer of large DNA fragments from agarose gels and rapid hybridization,23 precipitation procedures for the quantitation of high-density lipoprotein cholesterol,24 and inhibition of virion binding to CD4+ cells.25

Materials
Loading

References

1.
Pasteur, L 1861 On the viscous fermentation and the butyrous fermentation Bull. Soc. Chim. Paris 11 30-31.
2.
Scheibler, C., Z.. 1874. Ver. Dtsch. Zucker-Ind. 24,309-335.
3.
Robyt, J.F 1986 Encyclopedia of Polymer Sci. Eng J.I.Kroschwitz (ed.), 4, 752-767 Wiley-VCH..
4.
Cheetham NW, Fiala-Beer E, Walker GJ. 1990. Dextran structural details from high-field proton NMR spectroscopy. Carbohydrate Polymers. 14(2):149-158. http://dx.doi.org/10.1016/0144-8617(90)90027-p
5.
Naessens M, Cerdobbel A, Soetaert W, Vandamme EJ. 2005. Leuconostoc dextransucrase and dextran: production, properties and applications. J. Chem. Technol. Biotechnol.. 80(8):845-860. http://dx.doi.org/10.1002/jctb.1322
6.
Kim D, Robyt JF, Lee S, Lee J, Kim Y. 2003. Dextran molecular size and degree of branching as a function of sucrose concentration, pH, and temperature of reaction of Leuconostoc mesenteroides B-512FMCM dextransucrase. Carbohydrate Research. 338(11):1183-1189. http://dx.doi.org/10.1016/s0008-6215(03)00148-4
7.
Côté GL, Leathers TD. 2005. A method for surveying and classifying Leuconostoc spp. glucansucrases according to strain-dependent acceptor product patterns. J IND MICROBIOL BIOTECHNOL. 32(2):53-60. http://dx.doi.org/10.1007/s10295-004-0194-x
8.
Maina NH, Tenkanen M, Maaheimo H, Juvonen R, Virkki L. 2008. NMR spectroscopic analysis of exopolysaccharides produced by Leuconostoc citreum and Weissella confusa. Carbohydrate Research. 343(9):1446-1455. http://dx.doi.org/10.1016/j.carres.2008.04.012
9.
Marszalek PE, Oberhauser AF, Pang Y, Fernandez JM. 1998. Polysaccharide elasticity governed by chair?boat transitions of the glucopyranose ring. Nature. 396(6712):661-664. http://dx.doi.org/10.1038/25322
10.
Banas J, Vickerman M. 2003. Glucan-binding Proteins of the Oral Streptococci. Critical Reviews in Oral Biology & Medicine. 14(2):89-99. http://dx.doi.org/10.1177/154411130301400203
11.
M J Meddens J Thompson P C Leijh R van Furth 1984 Role of granulocytes in the induction of an experimental endocarditis with a dextran-producing Streptococcus sanguis and its dextran-negative mutant Br J Exp Pathol 65(2) 257-65.
12.
Kato, I., Fragrance J., 33, 59-64 (2005)..
13.
Mehvar R. 2000. Dextrans for targeted and sustained delivery of therapeutic and imaging agents. Journal of Controlled Release. 69(1):1-25. http://dx.doi.org/10.1016/s0168-3659(00)00302-3
14.
Terg R, Miguez CD, Castro L, Araldi H, Dominguez S, Rubio M. 1996. Pharmacokinetics of Dextran-70 in patients with cirrhosis and ascites undergoing therapeutic paracentesis. Journal of Hepatology. 25(3):329-333. http://dx.doi.org/10.1016/s0168-8278(96)80119-x
15.
Porsch B, Sundelöf L. 1994. Size-exclusion chromatography and dynamic light scattering of dextrans in water: Explanation of ion-exclusion behaviour. Journal of Chromatography A. 669(1-2):21-30. http://dx.doi.org/10.1016/0021-9673(94)80333-1
16.
Neyestani TR, Djalali M, Pezeshki M. 2003. Isolation of ?-lactalbumin, ?-lactoglobulin, and bovine serum albumin from cow?s milk using gel filtration and anion-exchange chromatography including evaluation of their antigenicity. Protein Expression and Purification. 29(2):202-208. http://dx.doi.org/10.1016/s1046-5928(03)00015-9
17.
Guadalupe Penzol Pilar Armisén Roberto Fernández‐Lafuente Lorenzo Rodés José M. Guisán 1998 Use of dextrans as long and hydrophilic spacer arms to improve the performance of immobilized proteins acting on macromolecules Biotechnol. Bioeng 60 518-523.
18.
Gibson L, Coughlin R. 2002. Optimization of High Molecular Weight Pullulan Production by Aureobasidium pullulans in Batch Fermentations. Biotechnol. Prog.. 18(3):675-678. http://dx.doi.org/10.1021/bp0200043
19.
Leathers TD. 2003. Biotechnological production and applications of pullulan. Applied Microbiology and Biotechnology. 62(5-6):468-473. http://dx.doi.org/10.1007/s00253-003-1386-4
20.
Catley B. 1970. Pullulan, a relationship between molecular weight and fine structure. 10(3):190-193. http://dx.doi.org/10.1016/0014-5793(70)80450-1
21.
Viel S, Capitani D, Mannina L, Segre A. 2003. Diffusion-Ordered NMR Spectroscopy:  A Versatile Tool for the Molecular Weight Determination of Uncharged Polysaccharides. Biomacromolecules. 4(6):1843-1847. http://dx.doi.org/10.1021/bm0342638
22.
Nishinari K, Kohyama K, Williams PA, Phillips GO, Burchard W, Ogino K. 1991. Solution properties of pullulan. Macromolecules. 24(20):5590-5593. http://dx.doi.org/10.1021/ma00020a017
23.
Wahl GM, Stern M, Stark GR. 1979. Efficient transfer of large DNA fragments from agarose gels to diazobenzyloxymethyl-paper and rapid hybridization by using dextran sulfate.. Proceedings of the National Academy of Sciences. 76(8):3683-3687. http://dx.doi.org/10.1073/pnas.76.8.3683
24.
Warnick GR, Benderson J, Albers JJ. 1982. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol.. 28(6):1379-1388. http://dx.doi.org/10.1093/clinchem/28.6.1379
25.
Mitsuya H, Looney D, Kuno S, Ueno R, Wong-Staal F, Broder S. 1988. Dextran sulfate suppression of viruses in the HIV family: inhibition of virion binding to CD4+ cells. Science. 240(4852):646-649. http://dx.doi.org/10.1126/science.2452480

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.